Delivery Order SPE2DH22D0002-SPE2D424F145C

Award Date 2/12/24
Potential Completion Date 2/20/24
Potential Value $20K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a foreign-owned for-profit manufacturer of diagnostic technologies. The contract, valued at $59,472.00, is for the provision of XTAG Cystic Fibrosis Kits. The contract has a period of performance through February 12, 2025 and does not have a small business set-aside designation. Luminex is the prime contractor and has experience providing a range of specialized diagnostic...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies headquartered in Austin, Texas. The contract has a ceiling value of $60,245.30 and an ultimate completion date of March 11, 2025. The contract is for the delivery of XTAG Cystic Fibrosis Kits, which are specialized diagnostic products used for cystic fibrosis testing. Luminex, as the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $59,472.00, is for the delivery of XTAG Cystic Fibrosis Kits. The contract is a firm fixed-price delivery order, without any set-aside designation. Luminex Corporation, based in Austin, Texas, is the prime contractor and has previously received other federal contracts and grants, including a...
This is a delivery order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies, for the delivery of 4,563,918,990 XTAG Cystic Fibrosis Kits. The $19,824.00 firm-fixed-price award was made on March 11, 2024 by the Defense Logistics Agency, a defense agency under the Department of Defense, with a performance period ending on March 18, 2024. The award is not designated as a set-aside. Luminex has provided similar immunology products and services to...
The Defense Logistics Agency Troop Support Medical awarded a $19,824.00 firm fixed-price delivery order to Luminex Corp, a foreign-owned, for-profit manufacturer of goods, to provide XTAG Cystic Fibrosis Kits. This award does not have a set-aside designation. Luminex is a provider of multiplex diagnostic solutions and serves as a prime contractor delivering specialized testing platforms and related products to government agencies such as the Centers for Disease Control and Prevention, Department...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies. The $29,736.00 firm fixed price contract is for the delivery of XTAG Cystic Fibrosis Kits, which are diagnostic products used in clinical laboratories and research settings. The contract has an ultimate completion date of April 26, 2024. Luminex often serves as a prime contractor for federal agencies, providing specialized multiplex testing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies. The contract, valued at $30,082.50, is for the procurement of XTAG Cystic Fibrosis Kits, which are used for clinical testing and research applications. The contract has an ultimate completion date of December 17, 2024. Luminex is the prime contractor and has not been awarded any federal grants, but has received subcontract and task...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the supply of XTAG Cystic Fibrosis Kits, with a ceiling value of $59,541.30 and a period of performance through January 7, 2025. The award is structured as a Firm Fixed Price contract. Luminex has previously received other prime contract awards and indefinite delivery vehicles from government agencies, including the Centers for...
This $62,672 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for the delivery of XTAG Cystic Fibrosis Kits, which are used for clinical laboratory testing. Luminex has provided similar immunology services, laboratory supplies, and diagnostic testing products to various federal agencies in the past, often through prime contracts...
This is a firm fixed-price purchase order awarded by the Air Education and Training Command (AETC) of the U.S. Department of Defense to Luminex Corp, a manufacturer of biological testing technologies. The contract is for the provision of XTAG Cystic Fibrosis Kits, with a ceiling value of $79,296.00 and a completion date of November 4, 2019. The contract was awarded on a competitive basis, with no set-aside designation. Luminex Corp is a foreign-owned, for-profit organization that has...
  • SPE2DH22D0002
    Indefinite Delivery Contract
  • SPE2DH22D0002-SPE2D424F145C
    Delivery Order

This is a $19,824.00 delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies. The contract is for XTAG CYSTIC FIBROSIS KIT and has a completion date of February 20, 2024. The contract is a firm fixed price type and is not set aside. Luminex has provided multiplex diagnostic solutions, laboratory supplies, and other biomedical products and services to various federal agencies through prime and subcontract awards, supporting clinical testing programs and biomedical research efforts. This order is likely part of a larger procurement vehicle, such as an indefinite delivery contract or a blanket purchase agreement, which the company has previously received to streamline the acquisition of its proprietary platforms and testing products.

Generated 5/13/24, 9:10 AM